![Matthew DeLawder](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Matthew DeLawder worked as an Accounting Director at Biohaven Pharmaceutical Holding Co. Ltd. from 2018 to 2023.
Prior to that, he was a Senior Manager-Global Research & Development at Alexion Pharmaceuticals, Inc. from 2013 to 2018.
He also held the position of Senior Manager-Global Research & Development at Bayer Healthcare LLC.
Ehemalige bekannte Positionen von Matthew DeLawder
| Unternehmen | Position | Ende |
|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Comptroller/Controller/Auditor | 01.04.2023 |
| ALEXION PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2018 |
Bayer Healthcare LLC
 Bayer Healthcare LLC Pharmaceuticals: MajorHealth Technology Provides healthcare and pharmaceutical medicines | Technik-/Wissenschafts-/F&E-Leiter | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
59
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Bayer Healthcare LLC
Bayer Healthcare LLC Pharmaceuticals: MajorHealth Technology Provides healthcare and pharmaceutical medicines | Health Technology |
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric diseases | Health Technology |
